Common Equity: The sum of all common equity items.
Allarity Therapeutics, Inc. (ALLR) had Common Equity of $9.83M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.32M |
|
$-11.23M |
|
-- |
|
$0.32M |
|
$12.93M |
|
$-12.61M |
|
$1.37M |
|
$-11.23M |
|
$-11.23M |
|
$-11.23M |
|
$-11.23M |
|
$-11.23M |
|
$-11.23M |
|
$-12.61M |
|
$-12.62M |
|
14.38M |
|
14.38M |
|
$-0.78 |
|
$-0.78 |
|
| Balance Sheet Financials | |
$17.93M |
|
$0.33M |
|
$0.33M |
|
$18.26M |
|
$8.43M |
|
-- |
|
-- |
|
$8.43M |
|
|
Common Equity |
$9.83M |
$9.83M |
|
$9.83M |
|
16.08M |
|
| Cash Flow Statement Financials | |
$-14.82M |
|
$-0.01M |
|
$10.65M |
|
$19.53M |
|
$14.69M |
|
$-4.85M |
|
$0.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
100.00% |
|
-3939.06% |
|
-3939.06% |
|
-3943.12% |
|
-3509.69% |
|
-3509.69% |
|
$-14.83M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.37 |
|
987.78 |
|
-114.28% |
|
-114.28% |
|
-61.51% |
|
-114.28% |
|
$0.61 |
|
$-1.03 |
|
$-1.03 |
|